James Solomon

2.6k total citations · 1 hit paper
45 papers, 1.8k citations indexed

About

James Solomon is a scholar working on Dermatology, Epidemiology and Molecular Biology. According to data from OpenAlex, James Solomon has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Dermatology, 16 papers in Epidemiology and 13 papers in Molecular Biology. Recurrent topics in James Solomon's work include Hedgehog Signaling Pathway Studies (12 papers), Nonmelanoma Skin Cancer Studies (12 papers) and Cancer and Skin Lesions (6 papers). James Solomon is often cited by papers focused on Hedgehog Signaling Pathway Studies (12 papers), Nonmelanoma Skin Cancer Studies (12 papers) and Cancer and Skin Lesions (6 papers). James Solomon collaborates with scholars based in United States, Germany and Belgium. James Solomon's co-authors include Anne Lynn S. Chang, John D. Hainsworth, Aleksandar Sekulić, Michael R. Migden, Sarah T. Arron, Simon Yoo, Karl D. Lewis, Charles M. Rudin, Ellen S. Marmur and Axel Hauschild and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

James Solomon

42 papers receiving 1.7k citations

Hit Papers

Efficacy and Safety of Vismodegib in Advanced Basal-Cell ... 2012 2026 2016 2021 2012 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
    2012 1.0k citations Aleksandar Sekulić, Michael R. Migden et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Solomon United States 14 1.3k 767 745 436 196 45 1.8k
Ivor Caro United States 25 670 0.5× 505 0.7× 813 1.1× 572 1.3× 115 0.6× 65 2.2k
D. Innocenzi Italy 20 279 0.2× 269 0.4× 433 0.6× 376 0.9× 107 0.5× 70 1.4k
Marco Manfredini Italy 23 229 0.2× 316 0.4× 588 0.8× 473 1.1× 63 0.3× 90 1.4k
Ibrahim Khalifeh Lebanon 20 311 0.2× 236 0.3× 116 0.2× 357 0.8× 79 0.4× 62 1.3k
Sergio Chimenti Italy 19 167 0.1× 320 0.4× 578 0.8× 501 1.1× 53 0.3× 40 1.2k
Howard L. Stoll United States 20 191 0.2× 516 0.7× 684 0.9× 462 1.1× 66 0.3× 41 1.1k
M Partridge United Kingdom 25 759 0.6× 187 0.2× 99 0.1× 755 1.7× 139 0.7× 51 1.8k
J.M. McGregor United Kingdom 24 215 0.2× 730 1.0× 609 0.8× 577 1.3× 81 0.4× 50 1.5k
U. Zimmermann France 20 329 0.3× 139 0.2× 587 0.8× 363 0.8× 64 0.3× 51 1.3k
Dan Rowe United States 8 291 0.2× 2.1k 2.7× 1.5k 2.1× 1.1k 2.5× 35 0.2× 11 2.3k

Countries citing papers authored by James Solomon

Since Specialization
Citations

This map shows the geographic impact of James Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Solomon more than expected).

Fields of papers citing papers by James Solomon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Solomon. The network helps show where James Solomon may publish in the future.

Co-authorship network of co-authors of James Solomon

This figure shows the co-authorship network connecting the top 25 collaborators of James Solomon. A scholar is included among the top collaborators of James Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Solomon. James Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Duffin, Kristina Callis, Luis Daniel Mazzuoccolo, Maria Esposito, et al.. (2022). Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of Rheumatology. 50(1). 131–143. 6 indexed citations
3.
Marson, Justin W., James Solomon, Matt Leavitt, et al.. (2021). The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers. Journal of the American Academy of Dermatology. 84(4). 1100–1103. 36 indexed citations
4.
Brooks, Ian, et al.. (2021). 377 Using artificial intelligence (AI) to compare patient perspective of PD-1 and BRAF inhibitors for melanoma treatment. Journal of Investigative Dermatology. 141(5). S66–S66. 1 indexed citations
5.
Aneja, Sanjay, et al.. (2020). Overview of genetic signaling pathway interactions within cutaneous malignancies. Journal of Cancer Metastasis and Treatment. 2020. 8 indexed citations
6.
Dellavalle, Robert P., et al.. (2020). LB945 Using artificial intelligence to understand patient perspectives towards treatment of dermatological diseases. Journal of Investigative Dermatology. 140(7). B10–B10. 2 indexed citations
7.
Cortes, Jörge E., Ralf Gutzmer, Mark W. Kieran, & James Solomon. (2019). Hedgehog signaling inhibitors in solid and hematological cancers. Cancer Treatment Reviews. 76. 41–50. 92 indexed citations
8.
Dellavalle, Robert P., et al.. (2018). Perceptions of tanning risk among melanoma patients with a history of indoor tanning.. PubMed. 101(1). 47;50;55–47;50;55. 2 indexed citations
9.
Solomon, James, et al.. (2018). Acne treatment: analysis of acne-related social media posts and the impact on patient care.. PubMed. 102(1). 41–43. 8 indexed citations
10.
Solomon, James, et al.. (2018). Urticaria from penicillin as the sole clue to acute onset of disabling arthritis. SHILAP Revista de lepidopterología. 9(1). 91–92.
11.
Egeberg, Alexander, Jashin J. Wu, Neil J. Korman, et al.. (2018). Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3. Journal of the American Academy of Dermatology. 79(1). 104–109.e8. 51 indexed citations
12.
13.
Solomon, James, et al.. (2017). 134 The study of basal cell carcinoma nevus syndrome through continuous quality improvement assessment. Journal of Investigative Dermatology. 137(5). S23–S23. 1 indexed citations
14.
15.
Chang, Anne Lynn S., Karl D. Lewis, Sarah T. Arron, et al.. (2016). Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma. Oncotarget. 7(46). 76118–76124. 17 indexed citations
16.
Sekulić, Aleksandar, Michael R. Migden, Karl D. Lewis, et al.. (2015). Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. Journal of the American Academy of Dermatology. 72(6). 1021–1026.e8. 154 indexed citations
17.
Boehncke, Wolf‐­Henning, et al.. (2014). Safety and Efficacy of Therapies for Skin Symptoms of Psoriasis in Patients with Psoriatic Arthritis: A Systematic Review. The Journal of Rheumatology. 41(11). 2301–2305. 11 indexed citations
18.
Chang, Anne Lynn S., James Solomon, John D. Hainsworth, et al.. (2013). Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib. Journal of the American Academy of Dermatology. 70(1). 60–69. 138 indexed citations
19.
OʼNeill, Jenna L., Yun Sun Lee, James Solomon, et al.. (2013). Quantifying and Characterizing Adverse Events in Dermatologic Surgery. Dermatologic Surgery. 39(6). 872–878. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivor Caro Breakdown of academic impact, for papers by D. Innocenzi Breakdown of academic impact, for papers by Marco Manfredini Breakdown of academic impact, for papers by Ibrahim Khalifeh Breakdown of academic impact, for papers by Sergio Chimenti Breakdown of academic impact, for papers by Howard L. Stoll Breakdown of academic impact, for papers by M Partridge Breakdown of academic impact, for papers by J.M. McGregor Breakdown of academic impact, for papers by U. Zimmermann Breakdown of academic impact, for papers by Dan Rowe
Rankless by CCL
2026